Opdivo

$8,000

Opdivo, is a medication used to treat cancer. It is used as a first line treatment for inoperable or metastatic melanoma in combination with ipilimumab if the cancer does not have a mutation in BRAF, as a second-line treatment following treatment with ipilimumab and if the cancer has a mutation in BRAF, with a BRAF inhibitor, as a second-line treatment for squamous non-small cell lung cancer, and as a second-line treatment for renal cell carcinoma. We help patients and doctors get access to medicines at the lowest price worldwide.

Oncology Urothelial Carcinoma, Colorectal Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Lymphoma, Skin Cancer
Mode of Action Monoclonal antibody (immunotherapy)
Administration Intravenous
Regulatory agency approval European Medical Agency (EMA), European Union, Food and Drug Administration (FDA), USA, Pharmaceuticals and Medical Devices Agency (PMDA), Japan, Therapeutic Goods Administration (TGA), Australia
Strength 10 milligram / millilitre
Package 1 Vials
Clear
error: Content is protected !!
WhatsApp chat